MAETZOLD DEREK J sold CSTL

August 4, 2026 · Form 4 insider transaction

MAETZOLD DEREK J sold 8,421 shares of Castle Biosciences, Inc. at $30.79 per share, a transaction worth $259.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
8,421
Price
$30.79
Total value
$259.3K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 4, 2026
Filing dateAugust 6, 2026
Shares owned after33,414
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 3, 2025.; This transaction was executed in multiple trades at prices ranging from $30.000 to $30.995, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR